Skin Penetration Enhancer

Chemical enhancers work by a small number of mechanisms: disordering the intercellular lipid lamellae, extracting lipid outright, hydrating corneocytes, or improving how the active partitions into the barrier. Oleic acid is the archetype of lipid fluidisation; propylene glycol and ethanol act largely as partitioning solvents; terpenes such as limonene and menthol disrupt lipid packing; urea and surfactants act on the protein phase. Microneedling, iontophoresis and sonophoresis breach the barrier instead of remodelling it.

Enhancement is reported as a ratio of flux with and without the enhancer, and in-vitro figures from a few-fold up to roughly tenfold are typical for small molecules. The classic solvents show the cost: dimethyl sulfoxide enhances meaningfully only at very high concentrations, at which it is itself irritating. Effects are also active-specific, so an enhancer characterised with a small lipophilic drug says little about a charged peptide.

The governing tradeoff is that enhancement and irritation share a mechanism. Anything that disorders barrier lipids enough to admit more drug also lets more water out and exposes viable epidermis to the rest of the formulation, so candidates are judged on an enhancement-to-irritation ratio rather than enhancement alone. That is why the most aggressive enhancers appear in transdermal patches for potent drugs, not daily cosmetics.

The misreading to watch is scale. Enhancer studies are frequently run on excised rodent skin, markedly more permeable than human skin, so the ratios do not transfer. More fundamentally, a tenfold increase on a near-zero baseline is still near zero: for a peptide above a thousand daltons, chemical enhancement rarely converts exclusion into meaningful delivery, and listing an enhancer demonstrates nothing about arrival.